Artera and Atlantic Health System have launched AI-powered agents to automate and personalize colonoscopy patient outreach, targeting a persistent weak spot in preventive care: getting patients to show up, fully prepped, for their screenings.

Why does this matter? Colorectal cancer is the second leading cause of cancer deaths in the U.S., but colonoscopy attendance and prep rates remain stubbornly low. The CDC recommends regular screenings for adults aged 45 to 75, yet missed appointments and inadequate preparation undermine both patient outcomes and health system efficiency.

AI Steps Into the Patient Engagement Gap

The partnership integrates Artera’s agentic AI platform directly into Atlantic Health’s clinical workflows. The agents handle multi-channel outreach—SMS, voice, and email—guiding patients through preparation steps, answering questions, and sending reminders. For Atlantic Health, which serves over 6 million people across New Jersey and Pennsylvania, the scale is significant.

By automating these touchpoints, the system aims to reduce no-shows and incomplete preps—two major pain points for gastroenterology departments. It also frees up staff from repetitive administrative work, allowing them to focus on higher-value tasks.

Agentic AI: Not Just Chatbots

This isn’t just another round of automated texts. Artera’s agentic AI is designed for two-way, context-aware conversations, adapting to patient responses and escalating to human staff when needed. The company, formerly known as WELL Health, has raised over $97 million to date, betting that healthcare’s patient engagement problem is ripe for automation.

Atlantic Health’s deployment is one of the first large-scale tests of agentic AI for a high-stakes, compliance-heavy workflow. Early signals suggest that AI-driven outreach can move the needle on both attendance and prep quality—metrics that directly impact clinical outcomes and reimbursement.

Healthcare’s AI Adoption Curve Gets Steeper

The move comes as health systems, under pressure to do more with less, are accelerating adoption of AI-driven operational tools. Patient engagement is a natural target: it’s high-volume, rules-based, and often neglected due to staffing constraints. But it’s also sensitive—missteps can erode trust or trigger regulatory headaches.

Artera’s platform is built to thread that needle, promising HIPAA-compliant, EHR-integrated automation that doesn’t feel robotic to patients. For health systems, the appeal is clear: boost throughput, reduce manual workload, and potentially improve quality metrics tied to reimbursement.

What to Watch

Will agentic AI actually drive measurable gains in colonoscopy attendance and prep? Atlantic Health will be a closely watched case study. If the numbers move, expect rapid copycat deployments across other high-value, high-friction procedures—think mammography, cardiac screening, and chronic disease management.

What This Means

For founders in health-tech, this is a green light for agentic AI that goes beyond basic automation. The bar is rising: health systems want solutions that integrate deeply, handle real-world complexity, and deliver clear ROI. Building for multi-channel, context-aware workflows isn’t optional—it’s table stakes.

For the industry, the trajectory is clear: patient engagement is moving from human-intensive to AI-augmented at scale. The winners will be those who can prove clinical and operational impact—not just engagement metrics, but actual reductions in no-shows, improved outcomes, and less staff burnout. Regulatory scrutiny will follow, but so will budget dollars.

The second-order effect? Expect a shift in how health systems think about staff roles and patient relationships. As AI agents take on more patient-facing tasks, the definition of "frontline" work will change. The challenge—and the opportunity—is to make automation feel like care, not cost-cutting. The next 18 months will tell us if agentic AI can deliver on that promise, or if it’s just another layer of digital noise.